Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

ZEAL

Press ReleasesTotal number of shares and voting rights in Zealand Pharma at September 30, 2022

2y ago

ZEAL

PremiumMarket News

Zealand Pharma’s (NASDAQ:ZEAL) Phase 3 SBS Trial Sees Positive Results

2y ago

ZEAL

PremiumPress Releases

Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1)

2y ago

ZEAL

PremiumPress Releases

Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)

2y ago

ZEAL

PremiumPress Releases

Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE Meeting

2y ago

ZEAL

PremiumPress ReleasesZealand Pharma grants warrants to employees in Denmark

2y ago

ZEAL

Premium

Press Releases

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

2y ago

ZEAL

Premium

Press Releases

Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference

2y ago

ZEAL

PremiumPress Releases

Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon)

2y ago

ZEAL

PremiumPress Releases

Total number of shares and voting rights in Zealand Pharma at August 31, 2022

2y ago

ZEAL

PremiumPress Releases

Zealand Pharma Appoints Henriette Wennicke as Chief Financial Officer

2y ago

ZEAL

PremiumPress Releases

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

2y ago

ZEAL

PremiumPress ReleasesZealand Pharma Announces Financial Results for the First Half of 2022

2y ago

ZEAL

Updated notice to holders of ADSs regarding termination of Deposit Agreement

Premium

Press Releases

Updated notice to holders of ADSs regarding termination of Deposit Agreement

2y ago

ZEAL

Premium

Press Releases

Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select Market

2y ago

ZEAL

PremiumPress Releases

Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022

2y ago

ZEAL

PremiumPress Releases

Total number of shares and voting rights in Zealand Pharma at June 30, 2022

2y ago

ZEAL

PremiumPress Releases

Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022

2y ago

ZEAL

PremiumPress Releases

Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual American Diabetes Association Scientific Sessions and Announces Dapiglutide to Move into Phase 2 Trial for Obesity

2y ago

ZEAL

PremiumPress ReleasesZealand Pharma completes registration of capital increase

2y ago

ZEAL

Premium

Press Releases

Zealand Pharma to Participate in Upcoming Investor Conferences

2y ago

ZEAL

Premium

Press Releases

Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Officer

2y ago

ZEAL

ZEAL

Trending

Indices

Stocks

ETFs